Novel Lactobacillus reuteri DB2 strain and use of the same

摘要

The present invention relates to a new Lactobacillus reuteri DB2 strain (KACC 92293P) and uses thereof, and the new Lactobacillus reuteri DB2 strain (KACC 92293P) of the present invention has an activity of improving intestinal flora and at the same time NK (Natural killer) cell activity and immune response-related cytokine production promoting activity, so it can be used in the manufacture of functional foods and pharmaceuticals for improving intestinal function and immune enhancement of humans as well as companion animals, and furthermore, for enteral use, probiotics, feed compositions, and companion animals It can also be usefully used in the manufacture of snacks.